All data are based on the daily closing price as of May 12, 2026
i
Ildong Pharmaceutical
249420.KO
15.36 USD
-0.04
-0.26%
Overview
Last close
15.36 usd
Market cap
483.97M usd
52 week high
30.05 usd
52 week low
7.11 usd
Target price
30.18 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
1.2671
Price/Book Value
2.9536
Enterprise Value
541.49M usd
EV/Revenue
1.424
EV/EBITDA
12.1393
Key financials
Revenue TTM
380.27M usd
Gross Profit TTM
147.28M usd
EBITDA TTM
26.76M usd
Earnings per Share
N/A usd
Dividend
0.13 usd
Total assets
397.19M usd
Net debt
37.27M usd
About
Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-cancer, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central nervous system, dental, endocrine and metabolic system, gastrointestinal system, respiratory system, and urogenital system applications. It also provides raw material drugs; health foods and foods; beverages; cosmetics; medical devices for scar treatment; and other drugs for treating thick wounds, osteoarthritis, periarthritis of shoulder, and artificial tears, as well as feminine cleanser products. The company was founded in 1941 and is headquartered in Seoul, South Korea.